Bone repair by transplantation of hTERT-immortalized human mesenchymal stem cells in mice

Transplantation

Volumn 88, Issue 3, 2009, Pages 346-353

  Nakahara, Hiroyuki ^a   Misawa, Haruo ^a   Hayashi, Takahiro ^a   Kondo, Eisaku ^a   Yuasa, Takeshi ^a   Kubota, Yasuhiro ^a   Seita, Masayuki ^a   Kawamoto, Hironobu ^a   Hassan, Wael A R A ^a   Hassan, Reham A R A ^a   Javed, Shahid M ^a   Tanaka, Masato ^a   Endo, Hirosuke ^a   Noguchi, Hirofumi ^b   Matsumoto, Shinichi ^b   Takata, Katsuyoshi ^a   Tashiro, Yuichi ^a   Nakaji, Shuhei ^c   Ozaki, Toshifumi ^a   Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b BAYLOR RESEARCH INSTITUTE   (United States)

^c OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Bone marrow; hTERT; Mesenchymal stem cells

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; COMPLEMENTARY DNA; OSTEOCALCIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL TRAIT; BONE DEFECT; BONE DEVELOPMENT; BONE REGENERATION; BONE REMODELING; CALVARIA; CARTILAGE CELL; CELL GROWTH; CELL IMMORTALIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; REGENERATIVE MEDICINE;

ADIPOCYTES; ANIMALS; BIOLOGICAL MARKERS; BONE DISEASES; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CHONDROCYTES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; OSTEOBLASTS; OSTEOGENESIS; SKULL; TELOMERASE; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 69449095008     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ae5ba2     Document Type: Article

References (27)

1. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641.
2. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994; 56: 283.
3. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278. (Pubitemid 27065442)
4. Caplan AI. The mesengenic process. Clin Plast Surg 1994; 21: 429.
5. Haynesworth SE, Goshima J, Goldberg VM, et al. Characterization of cells with osteogenic potential from human marrow. Bone 1992; 13: 81.
6. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143.
7. Egrise D, Martin D, Vienne A, et al. The number of fibroblastic colonies formed from bone marrow is decreased and the in vitro proliferation rate of trabecular bone cells increased in aged rats. Bone 1992; 13: 355.
8. Jiang XR, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999; 21: 111. (Pubitemid 29036295)
9. Morales CP, Holt SE, Ouellette M, et al. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999; 21: 115. (Pubitemid 29036296)
10. Takeda Y, Mori T, Imabayashi H, et al. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? J Gene Med 2004; 6: 833. (Pubitemid 40228099)
11. Watanabe T, Shibata N, Westerman KA, et al. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation 2003; 75: 1873. (Pubitemid 36734645)
12. Kobayashi N, Fujiwara T, Westerman KA, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000; 287: 1258. (Pubitemid 30112146)
13. Totsugawa T, Yong C, Rivas-Carrillo JD, et al. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J Hepatol 2007; 47: 74. (Pubitemid 46817692)
14. Maruyama M, Kobayashi N, Westerman KA, et al. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation 2004; 77: 446. (Pubitemid 38209749)
15. Okamoto T, Aoyama T, Nakayama T, et al. Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 2002; 295: 354. (Pubitemid 34785842)
16. Bielby RC, Boccaccini AR, Polak JM, et al. In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng 2004; 10: 1518.
17. Misawa H, Kobayashi N, Soto-Gutierrez A, et al. PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant 2006; 15: 903. (Pubitemid 46174540)
18. Goldstein LJ, Chen H, Bauer RJ, et al. Normal human fibroblasts enable melanoma cells to induce angiogenesis in type I collagen. Surgery 2005; 138: 439. (Pubitemid 41415570)
19. Kakudo N, Shimotsuma A, Miyake S, et al. Bone tissue engineering using human adipose-derived stem cells and honeycomb collagen scaffold. J Biomed Mater Res A 2008; 84: 191. (Pubitemid 350244260)
20. Fouillard L, Bensidhoum M, Bories D, et al. Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia 2003; 17: 474. (Pubitemid 36266932)
21. Abdallah BM, Haack-Sorensen M, Burns JS, et al. Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. Biochem Biophys Res Commun 2005; 326: 527. (Pubitemid 39642757)
22. Buhler L, Kurilla-Mahon B, Chang Q, et al. Cryopreservation and mycophenolate therapy are detrimental to hematopoietic progenitor cells. Transplantation 2002; 74: 1159. (Pubitemid 35216112)
23. Narushima M, Kobayashi N, Okitsu T, et al.Ahuman beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 2005; 23: 1274. (Pubitemid 41486855)
24. Kobune M, Kawano Y, Ito Y, et al. Telomerized human multipotent mesenchymal cells can differentiate into hematopoietic and cobblestone area-supporting cells. Exp Hematol 2003; 31: 715. (Pubitemid 36945385)
25. Zhang X, Soda Y, Takahashi K, et al. Successful immortalization of mesenchymal progenitor cells derived from human placenta and the differentiation abilities of immortalized cells. Biochem Biophys Res Commun 2006; 351: 853. (Pubitemid 44715863)
26. Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 2003; 21: 257.
27. Kawashima T, Kagawa S, Kobayashi N, et al. Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res 2004; 10(1 Pt 1): 285. (Pubitemid 38114191)